Vertex Pharmaceuticals Inc. buy UBS Group AG
Start price
05.08.25
/
50%
€344.35
Target price
05.08.26
€478.40
Performance (%)
-5.91%
Price
05.08.25
€324.00
Summary
This prediction is currently active. With a performance of -5.91%, the BUY prediction by UBS_Group_AG is trending in the wrong direction. This prediction currently runs until 05.08.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Vertex Pharmaceuticals Inc. | -5.91% |
| iShares Core DAX® | -1.351% |
| iShares Nasdaq 100 | -1.453% |
| iShares Nikkei 225® | -0.021% |
| iShares S&P 500 | -1.326% |
Comments by UBS_Group_AG for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target lowered by analysts at UBS Group AG from $582.00 to $553.00. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by UBS_Group_AG for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€459.85
05.11.24
05.11.24
€536.01
05.11.25
05.11.25
-29.54%
05.08.25
05.08.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€459.95
17.10.24
17.10.24
€519.06
17.10.25
17.10.25
-29.56%
05.08.25
05.08.25